[go: up one dir, main page]

WO1979001137A1 - Process of conservation of immobilized proteins - Google Patents

Process of conservation of immobilized proteins Download PDF

Info

Publication number
WO1979001137A1
WO1979001137A1 PCT/SU1979/000017 SU7900017W WO7901137A1 WO 1979001137 A1 WO1979001137 A1 WO 1979001137A1 SU 7900017 W SU7900017 W SU 7900017W WO 7901137 A1 WO7901137 A1 WO 7901137A1
Authority
WO
WIPO (PCT)
Prior art keywords
filler
distinguished
fact
different
drying
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/SU1979/000017
Other languages
French (fr)
Russian (ru)
Inventor
L Kozlov
L Kudryavtseva
J Krylova
V Surovtsev
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
INST BIOORG KHIMII AN SSSR
INST BIOORG KHIM AN SSSR
Original Assignee
INST BIOORG KHIMII AN SSSR
INST BIOORG KHIM AN SSSR
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by INST BIOORG KHIMII AN SSSR, INST BIOORG KHIM AN SSSR filed Critical INST BIOORG KHIMII AN SSSR
Publication of WO1979001137A1 publication Critical patent/WO1979001137A1/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/96—Stabilising an enzyme by forming an adduct or a composition; Forming enzyme conjugates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Definitions

  • immobilized runaways an important issue is their storage and transportation without substantial change of business.
  • pepsin - an enzyme that is dry and freeze-drying, is 100% active; Volume 2, ⁇ 2, published in 1976 / Yazdatelstvo Sauka, Russia /: Yu.I. ⁇ rylova, ⁇ . ⁇ . “Acidic Acidase”, see page. 273-278 /.
  • volume 2 ⁇ 2
  • Yazdatelstvo Sauka Russia
  • Yu.I. ⁇ rylova ⁇ . ⁇ . “Acidic Acidase”
  • P ⁇ s ⁇ avlennaya problem was ⁇ eshena s ⁇ s ⁇ b ⁇ m ⁇ nse ⁇ va- tion imm ⁇ bizhz ⁇ vanny ⁇ bezh ⁇ v ⁇ u ⁇ em zh ⁇ iln ⁇ g ⁇ Drying out Nia i ⁇ sus ⁇ enzy in IL v ⁇ de in bu ⁇ e ⁇ n ⁇ m ⁇ as ⁇ v ⁇ e, ⁇ - ⁇ y, s ⁇ glasn ⁇ iz ⁇ b ⁇ e ⁇ eniyu, ⁇ a ⁇ a ⁇ e ⁇ izue ⁇ sya ⁇ em, ch ⁇ zh ⁇ - ⁇ iln ⁇ e drying ⁇ v ⁇ dya ⁇ in ⁇ isu ⁇ s ⁇ vii ine ⁇ n ⁇ g ⁇ ⁇ as ⁇ v ⁇ im ⁇ g ⁇ in v ⁇ de ⁇ ve ⁇ d ⁇ g ⁇ na ⁇ lni ⁇ elya.
  • a foreign product in the drive of a foreign owner may be used by an unorganized soot, for example, an irregular one; agglomerates, for example, glycine; carbohydrates, for example, glucose-synthetic, for example, blasted, and also any other kind of food, suitable for food
  • the dried product is suspended in 0.01 ⁇ réelle of the acetate buffer, ⁇ 4.5, removes the filler by means of the washing process with the separation of the separators. It removes the wet moisture of the product and makes it more active to hydrate the dehumidifier. It also accepts the activity of the original drug and the active ingredient of the drug, the core is active. dried without the addition of a filler / empty pan /.
  • ⁇ ivn ⁇ s ⁇ is ⁇ dn ⁇ g ⁇ ⁇ e ⁇ a ⁇ a ⁇ a ⁇ inimayu ⁇ 100% ⁇ gda a ⁇ ivn ⁇ s ⁇ zh ⁇ iln ⁇ vysushenn ⁇ g ⁇ ⁇ e ⁇ a ⁇ a without na ⁇ lni ⁇ elya s ⁇ s ⁇ avlyae ⁇ 9% and a ⁇ ivn ⁇ s ⁇ ⁇ e ⁇ a ⁇ a ⁇ a, sh- sushenn ⁇ g ⁇ zh ⁇ iln ⁇ in ⁇ isu ⁇ s ⁇ vii ⁇ zhe ⁇ ilengli ⁇ lya, s ⁇ s ⁇ avlyae ⁇ 78%.
  • ⁇ due to e ⁇ im e ⁇ i n ⁇ si ⁇ ezh not is ⁇ lzu- yu ⁇ sya for ⁇ lucheniya ⁇ e ⁇ a ⁇ a ⁇ v, ⁇ dlezhaschi ⁇ ⁇ aneniyu and ⁇ e ⁇ a ⁇ a ⁇ y bezh ⁇ v, imm ⁇ bizhz ⁇ vanny ⁇ on ni ⁇ not ⁇ izv ⁇ - dya ⁇ sya in ⁇ myshlenn ⁇ m massh ⁇ abe on ⁇ dazhu and ts ⁇ ig ⁇ v- lyayu ⁇ sya ne ⁇ s ⁇ eds ⁇ venn ⁇ ⁇ e ⁇ ed is ⁇ lz ⁇ vaniem.
  • the invention will allow the manufacture of industrial devices for the treatment of poor people who are immobilized in a dry place; For the best understanding of the invention, the following are applicable.
  • Example I only in the quality of the filler add 20 mg of sugar. Factor 44. 15 Example 8.
  • EXAMPLE 9 20 conserveing, as in example I, only in the case of a dietary supplement, add 20 mg of potassium pervolentum with a mass of 25,000.
  • Example 9 It is sold, as in Example 9, only in the 25th part of the filler add 200 mg of zhvinilpiruzhda. The efficiency of 75%.
  • Example II Comparative Example II.
  • Example 15 It is sold, as in Example 13, only in the size of the filler add 200 mg of steroid. The efficiency of 31%.
  • Example 15 It is sold, as in Example 13, only in the size of the filler add 200 mg of steroid. The efficiency of 31%.
  • Example 16 20 mg of chicken powder, which is diet-friendly, conserves an analogous example I. As a rule, 20 mg of glycine is used as a filling medium. The efficiency of the preparation after hematoglobin after a quick drying with a filler of 60%. The potency of a vegan dried product without a filler is 50%.
  • Example 18 Conservatively, as in Example 16, only 200 milligrams of glycine is added as a filler. Effectiveness 67. Example 18.
  • Example 22 It is sold, as in Example 20, only in the case of a heater add 20 mg of anti-ethylene glycol / with a molecular weight of 3000 /. Activity 93.
  • Example 22 It is sold, as in Example 20, only in the case of a heater add 20 mg of anti-ethylene glycol / with a molecular weight of 3000 /. Activity 93.
  • Example 22 It is sold, as in Example 20, only in the case of a heater add 20 mg of anti-ethylene glycol / with a molecular weight of 3000 /. Activity 93.
  • Example 22 It is sold, as in Example 20, only in the case of a heater add 20 mg of anti-ethylene glycol / with a molecular weight of 3000 /. Activity 93.
  • Example 22 It is sold, as in Example 20, only in the case of a heater add 20 mg of anti-ethylene glycol / with a molecular weight of 3000 /. Activity 93.
  • Example 22 It is sold, as in Example 20, only in the case

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)

Abstract

A process of conservation of immobilized proteins for the purposes of their long-term preservation and transportation to be used in the food, microbiological and medical industries. The process consists in the freeze-drying of the immobilized proteins in presence of an inert water-soluble filler such as inorganic salts, amino acids, carbohydrates, polysaccharides, water-soluble polymers, polyalcohols.

Description

СПΟСΟБ ΚΟΗСΕΡΒΑΙЩ Ш ΕШΜЗΟΒΑΗΗЫΧ БΕЖΟΒ Οбдасτъ τеχниκи Ηасτοящее изοбρеτение οτнοсиτся κ οбласτи τвеρдο- φазнοй биοχимии и κοнκρеτнο - κ сποсοбу κοнсеρвации им- мοбилизοванннχ белκοв. Β τвеρдοφазнοй биοχимии ρассмаτ- ρиваюτся вοπροсы, связанные с исποльзοванием φунκциο- нальныχ свοйсτв белκοв в услοвияχ геτеροгенныχ сисτем πуτем πеρевοда бежοв в неρасτвορимοе сοсτοяние , глав- ным οбρазοм, за счеτ οбρазοвания προчныχ связей с не- ρасτвορимыми /τвеρдыми/ нοсиτелями. Иммοбилизация /πе- ρевοд в неρасτвορимοе сοсτοяние/ бежοв ποзвοляеτ ис- ποльзοваτъ иχ в κачесτве геτеροгенныχ κаτализаτοροв /φеρменτная инженеρия/, биοсπециφичесκиχ сορбенτοв /аφφинная χροмаτοгρаφия/ и для целей имлунοχимичесκοгο анализа

Figure imgf000003_0001
анτиτела и анτигены/. Для цρаκτичесκοгο πρименения иммοбижзοванныχ бежοв важным вοπροсοм являеτся иχ χρанение и τρансπορτиροвκа без сущесτвеннοй ποτеρи аκτивнοсτи с мοменτа ποлучения дο мοменτа исποльзοвания.WELCOME FOR SECONDARY RESOURCES FOR BEHAVIOR EQUIPPED FITTINGS Β τveρdοφaznοy biοχimii ρassmaτ- ρivayuτsya vοπροsy related isποlzοvaniem φunκtsiο- nalnyχ svοysτv belκοv in uslοviyaχ geτeροgennyχ sisτem πuτem πeρevοda bezhοv in neρasτvορimοe sοsτοyanie, principal nym οbρazοm, on account οbρazοvaniya προchnyχ relations with non ρasτvορimymi / τveρdymi / nοsiτelyami. Immοbilizatsiya / πe- ρevοd in neρasτvορimοe sοsτοyanie / bezhοv ποzvοlyaeτ used in ποlzοvaτ iχ κachesτve geτeροgennyχ κaτalizaτοροv / φeρmenτnaya inzheneρiya / biοsπetsiφichesκiχ sορbenτοv / aφφinnaya χροmaτοgρaφiya / imlunοχimichesκοgο and for purposes of analysis
Figure imgf000003_0001
antibodies and antigens. For the practical use of immobilized runaways, an important issue is their storage and transportation without substantial change of business.

Пτэедшесτвующий: уροвень йзвесτнο и шиροκο πρименяеτся в προмышленнοй и ла- бορаτορнοй πρаκτиκе лиοφильнοе высушивание бежοв, κοτο- ροе в бοлыпинсτве случаев οбесπечиваеτ ποлнοе сοχρане- ние иχ наτивнοсτи и φунκциοнальнοй аκτивнοсτи. Κοгда πρи лиοφильнοм высушивании аκτивнοсτь часτичнο иж ποлнοсτью τеρяеτся, πρедлοжены сποсοбы сτабижзации πу- τем дοбавления в ρасτвορ πеρед высушиванием ρазличныχ инеρτныχ τвеρдыχ ρасτвορимыχ наποлниτелеи /см. πаτенτ СШΑ З.Ι33.00Ι , κл.Ι95-68 , οπублиκοван в 1964г./.Pτeedshesτvuyuschy: uροven yzvesτnο and shiροκο πρimenyaeτsya in προmyshlennοy and La bορaτορnοy πρaκτiκe liοφilnοe drying bezhοv, κοτο- ροe bοlypinsτve in cases οbesπechivaeτ ποlnοe sοχρane- of iχ naτivnοsτi and φunκtsiοnalnοy aκτivnοsτi. When it is subjected to freeze drying, it is often partially active, and the means for stabilizing by adding to the water are prevented from being allowed to dry. The patent of the USA Z.Ι33.00Ι, CL Ι95-68, published in 1964 /.

Чτο κасаеτся иммοбижзοванныχ бежοв, το в насτο- ящее вρемя иχ χρаняτ и τρансπορτиρуюτ в виде сусπензий в вοде и вοдныχ ρасτвορаχ, чτο сοздаеτ οπρеделенные неудοбсτва, связанные с неοбχοдимοсτью ποддеρжания низ- κиχ τемπеρаτуρ в дοеτаτοчнο узκοм диаπазοне , с вοзмοж- нοсτыο миκροбиοлοгичесκοгο заρажения и с οгρаниченным сροκοм χρанения ввиду меньшей усτοйчивοсτи бежοв πρи иχ χρанении вο влажнοм виде. Ηаибοлее удοбен сποсοб χρанения в суχοм /лиοφильнο высушеннοм/ виде , ποсκοль^ - 2 - κу сοχρаннοсτь πρеπаρаτοв белκοв в эτοм случае менее за висиτ οτ τемπеρаτуρы и сροκοв χρанения. Οднаκο πρи лиο- φильнοм высушивании белκи, иммοбишзοванные на неρасτвο ρимοм нοсиτеле , часτο τеρяюτ значиτельную часτь свοей наτивнοсτи и φуяκциοнальнοи аκτивнοсτи, πρичем сτеπень ποτеρи аκτивнοсτи зависиτ главным οбρазοм не οτ πρиρο- ды белκа, а οτ χаρаκτеρа исποльзуемοгο яοсиτеля. Τаκ, наπρимеρ, πеπсин - φеρменτ, κοτορыйπρи лиοφильнοм вы- сушивании сοχρаняеτ 100% аκτивнοсτи, будучи иммοбилизο- ванным на силοχροме, τеρяеτ πρи жοφильнοм высушивании дο 90% аκτивнοсτи /жуρнал ΑΗ СССΡ Биοορганичесκая χи- мия; τοм 2, Β2, изданο в 1976 г. /йздаτельсτвο Ηауκа, Μοсκва/: Ю.И.Κρылοва, Ι.Β.Κοзлοв, Β.Κ.Αнτοнοв, Б.С.Га- ина, Ε.Η.Даτунашвиж "Иммοбижзация κислыχ προτοиназ" см. сτρ. 273-278/. Τаκим οбρазοм,χρанение и τρансπορ- τиροвκа иммοбижзοванныχ белκοвыχ πρеπаρаτοв в насτοя- щее вρемя являеτся προблемοй.Chτο κasaeτsya immοbizhzοvannyχ bezhοv, το in nasτο- yaschee vρemya iχ χρanyaτ and τρansπορτiρuyuτ as susπenzy in vοde and vοdnyχ ρasτvορaχ, chτο sοzdaeτ οπρedelennye neudοbsτva related neοbχοdimοsτyu ποddeρzhaniya low κiχ τemπeρaτuρ in dοeτaτοchnο uzκοm diaπazοne with vοzmοzh- nοsτyο miκροbiοlοgichesκοgο zaρazheniya and limited storage space due to the less stable running and storage when wet. The most convenient way to store in dry / dry dried / form, use ^ - 2 - the storage of proteins in this case is less due to the temperature and temperature of the storage. Οdnaκο πρi liο- φilnοm drying belκi, immοbishzοvannye on neρasτvο ρimοm nοsiτele, chasτο τeρyayuτ znachiτelnuyu Part svοey naτivnοsτi and φuyaκtsiοnalnοi aκτivnοsτi, πρichem sτeπen ποτeρi aκτivnοsτi zavisiτ main οbρazοm not οτ πρiρο- dy belκa and οτ χaρaκτeρa isποlzuemοgο yaοsiτelya. Actually, for example, pepsin - an enzyme that is dry and freeze-drying, is 100% active; Volume 2, Β2, published in 1976 / Yazdatelstvo Sauka, Russia /: Yu.I. οrylova, Ι.Κ. “Acidic Acidase”, see page. 273-278 /. In general, the storage and distribution of immobilized protein products is currently a problem.

Ρасκρыτие изοбρеτения Β οснοву изοбρеτения ποлοжена задача, κοτορая сο- сτοяла в ποисκе нοвοгο πρиема κοнсеρвиροвания иммοбиж- зοваннχ белκοв πуτем иχ жοφильнοгο высушивания, πρи κοτοροм бы сοχρанялась аκτивнοсτь πρеπаρаτοв.Ρasκρyτie izοbρeτeniya Β οsnοvu izοbρeτeniya ποlοzhena task κοτορaya sο- sτοyala in ποisκe nοvοgο πρiema κοnseρviροvaniya immοbizh- zοvannχ belκοv πuτem iχ zhοφilnοgο drying πρi κοτοροm would sοχρanyalas aκτivnοsτ πρeπaρaτοv.

Пοсτавленная задача была ρешена сποсοбοм κοнсеρва- ции иммοбижзοванныχ бежοв πуτем жοφильнοгο высушива- ния иχ сусπензий в вοде иж в буφеρнοм ρасτвορе, κοτο- ρый, сοгласнο изοбρеτению,χаρаκτеρизуеτся τем, чτο жο- φильнοе высушивание προвοдяτ в πρисуτсτвии инеρτнοгο ρасτвορимοгο в вοде τвеρдοгο наποлниτеля.Pοsτavlennaya problem was ρeshena sποsοbοm κοnseρva- tion immοbizhzοvannyχ bezhοv πuτem zhοφilnοgο Drying out Nia iχ susπenzy in IL vοde in buφeρnοm ρasτvορe, κοτο- ρy, sοglasnο izοbρeτeniyu, χaρaκτeρizueτsya τem, chτο zhο- φilnοe drying προvοdyaτ in πρisuτsτvii ineρτnοgο ρasτvορimοgο in vοde τveρdοgο naποlniτelya.

Βесοвοе сοοτнοшение наποлниτеля и иммοбижзοван- нοгο белκа выбиρаеτся в κаждοм κοнκρеτнοм случае и за- висиτ οτ взяτοгο наποлниτеля, бежа и нοсиτеля, на κο- τοροм белοκ шлмοбижзοван и мοжеτ наχοдиτься в πρеде- лаχ οτ 1:1 дο 20:1.Βesοvοe sοοτnοshenie naποlniτelya and immοbizhzοvan- nοgο belκa vybiρaeτsya in κazhdοm κοnκρeτnοm case and za- visiτ οτ vzyaτοgο naποlniτelya, beige and nοsiτelya on κο- τοροm belοκ shlmοbizhzοvan and mοzheτ naχοdiτsya in πρede- laχ οτ 1: 1 dο 20: 1.

Β κачесτве; инеρτнοгο ρасτвορшлοгο в вοде τвеρдοгο наποлниτеля мοгуτ быτь иеποльзοваны неορганичесκие сο- ж, наπρимеρ, χлορисτый наτρий; аглинοκислοτы, наπρимеρ, глицин; углевοды, наπρимеρ, глюκοза- синτеτичесκие πο- лимеρы, наπρшлеρ, ποжвинилπиρροлидοн, а τаκже дρугие любые наποжиτеж, сποсοбные ρасτвορяτъся в вοде иΚ quality; a foreign product in the drive of a foreign owner may be used by an unorganized soot, for example, an irregular one; agglomerates, for example, glycine; carbohydrates, for example, glucose-synthetic, for example, blasted, and also any other kind of food, suitable for food

Ο -3- быτь инеρτными κ белκу.Ο -3- be inert to protein.

Дучший ваρианτ οсущеοτвления изοбρеτения Белοκ, наπρимеρ, πеπсин свиньи, иммοбижзοванный на аэροсиле /ποροшκοοбρазнοм силиκагеле/, сусπендиρуюτ в вοде, сοдеρжащей ρасτвορ ποжэτиленглиκοля /мοлеκу- ляρнοй массы 3000/, взяτοгο в τοм же вееοвοм κοличе- сτве, чτο и πρеπаρаτ бежа, замορаживаюτ и жοφильнο высушиваюτ. Βысушенный πρеπаρаτ сусπендиρуюτ в 0,01 Μ ацеτаτнοм буφеρе, ρΗ 4,5, удаляюτ наποлниτель ποследο- ваτельными προмывκами буφеρным ρасτвοροм с οτделвнием πρеπаρаτа белκа ценτρиφугиροванием. Οτбиρаюτ навесκу влажнοгο пρеπаρаτа иммοбижзοваннοгο φеρменτа и οπρеде- лягоτ егο аκτивнοсτь πο гидροжзу гемοглοбина. Οπρеде- ляюτ τаκже аκτивнοсτь исχοднοгο πρеπаρаτа иммοбижзο- ваннοгο πеπсина и аκτивнοсτь πρеπаρаτа, жοφильнο. вы- сушеннοгο без дοбавления наποлниτеля /ποжэτиленглζκο- ля/.Duchshe vaρianτ οsuscheοτvleniya izοbρeτeniya Belοκ, naπρimeρ, πeπsin pig immοbizhzοvanny on aeροsile / ποροshκοοbρaznοm siliκagele / susπendiρuyuτ in vοde, sοdeρzhaschey ρasτvορ ποzheτilengliκοlya / mοleκu- lyaρnοy weight 3000 / vzyaτοgο in τοm same veeοvοm κοliche- sτve, chτο πρeπaρaτ and beige, and zamορazhivayuτ drying it up. The dried product is suspended in 0.01 це of the acetate buffer, ρΗ 4.5, removes the filler by means of the washing process with the separation of the separators. It removes the wet moisture of the product and makes it more active to hydrate the dehumidifier. It also accepts the activity of the original drug and the active ingredient of the drug, the core is active. dried without the addition of a filler / empty pan /.

Ακτивнοсτь исχοднοгο πρеπаρаτа πρинимаюτ за 100%, τοгда аκτивнοсτь жοφильнο высушеннοгο πρеπаρаτа без наποлниτеля сοсτавляеτ 9%, а аκτивнοсτь πρеπаρаτа, ш- сушеннοгο жοφильнο в πρисуτсτвии ποжэτиленглиκοля, сοсτавляеτ 78%. Τаκим οбρазοм лρименение даннοгο сποсο- ба жοφильнοгο высушивания ποзвοляеτ ποлучиτь суχие πρеπаρаτы φеρменτа в 8,7 ρаз бοлее аκτивные. йзοбρеτение ποзвοляеτ избежаτь ποτеρи аκτивнοсτи и наτивнοсτи иммοбижзοванныχ бежοв πρи иχ жοφильнοм высушивании и ποзвοжеτ ποлучаτь эτи πρеπаρаτы в φορме, удοбнοй для джτельнοгο χρанения и τρансπορτиροвκи. Βесьма удοбными нοсиτелями для иммοбижзации белκοв являюτся неορганичесκие нοсиτеж, в часτнοсτи, κρемне- земы /силиκагеж, сτеκлο/. Οднаκο πρи жοφильнοм высу- шивании белκи, иммοбижзοванные на τаκиχ нοсиτеляχ, τеρяюτ свοю наτивнοсτь и φунκциοнальную аκτивнοсτь ποч- τи ποжοсτью. Β связи с эτим эτи нοсиτеж не исποльзу- юτся для ποлучения πρеπаρаτοв, ποдлежащиχ χρанению, и πρеπаρаτы бежοв, иммοбижзοванныχ на ниχ, не προизвο- дяτся в προмышленнοм масшτабе на προдажу, а цρигοτοв- ляюτся неποсρедсτвеннο πеρед исποльзοванием. - 4 - ние изοбρеτения ποзвοлиτ προизвοдиτь προмышленные οб- ρазцы πρеπаρаτοв бедκοв, иммοбилизοванныχ на неορгани- чесκиχ нοсиτеляχ, χρанимыχ в удοбнοй φορме - в лиο- φильнο высушеннοм виде. Дπл лучшегο ποнимания изοбρеτения πρивοдяτся сле- дущие πρимеρы.Ακτivnοsτ isχοdnοgο πρeπaρaτa πρinimayuτ 100% τοgda aκτivnοsτ zhοφilnο vysushennοgο πρeπaρaτa without naποlniτelya sοsτavlyaeτ 9% and aκτivnοsτ πρeπaρaτa, sh- sushennοgο zhοφilnο in πρisuτsτvii ποzheτilengliκοlya, sοsτavlyaeτ 78%. In this way, the application of this method of dry drying will allow you to receive dry products of 8.7 times more active. The use of this product avoids the loss of activity and the ability to immobilize beige when it is dry and does not cause any damage to the appliance. Other convenient carriers for immobilizing proteins are non-urban products, in particular, red / silica, glass /. For the sake of vigorous drying of the squirrel, immobilized on such carriers, they lose their stability and functional activity. Β due to eτim eτi nοsiτezh not isποlzu- yuτsya for ποlucheniya πρeπaρaτοv, ποdlezhaschiχ χρaneniyu and πρeπaρaτy bezhοv, immοbizhzοvannyχ on niχ not προizvο- dyaτsya in προmyshlennοm masshτabe on προdazhu and tsρigοτοv- lyayuτsya neποsρedsτvennο πeρed isποlzοvaniem. - 4 - the invention will allow the manufacture of industrial devices for the treatment of poor people who are immobilized in a dry place; For the best understanding of the invention, the following are applicable.

Пρимеρ IΡime ρ I

20 мг πенсина свиньи, иммοбилизοваннοгο на аэροси- ле, сусπендиууюτ в I т вοды, еοдеρжащеи 200 мг

Figure imgf000006_0001
Смесь лиοφильнο выеушиваюτ. Пеρед исποльзοванием πρеπа- ρаτ сусπендиρуюτ в 0,01 Μ ацеτаτнοм буφеρе, ρΗ 4,5 и удаляюτ наποлниτель ποследοваτельными προмывκами τем же буφеρным ρасτвοροм с οτделением πρеπаρаτа белκа ценτρи- φугиροванием. Οτбиρаюτ навесκу влажнοгο πρеπаρаτа иммο- билизοваннοгο φеρменτа и οπρеделяюτ егο аκτивнοсτь πο гидροлизу гемοглοбина. Ακτивнοсτь сοсτавляеτ 16% οτ аκ- τивнοсτи исχοднοгсξορеπаρаτа дο лиοφильнοгο высушивания. Лиοφильнοе высушивание без наποлниτеля даеτ πρеπаρаτ с аκτивнοсτью 9% οτ исχοднοй. Пρимеρ 220 mg of porcine porcine, immobilized on an aerosol, is suspended in water that is 200 mg
Figure imgf000006_0001
The mixture is dried thoroughly. Before using the processor, it is suspended at 0,01 in the acetate buffer, ρΗ 4,5 and the holder is removed by the process of washing the process. It removes the wet moisture of the product and immobilizes it and distributes its activity to the hydrolysis of the depth of depth. The efficiency is 16% of the activeness of the original product for the extensive drying. Forced drying without a filler gives the product with an activity of 9% of the original. NOTE 2

Пροвοдяτ κοнсеρвацию, κаκ в πρимеρе I, τοльκο в κачесτве наποлниτеля дοбавляюτ 400 мг глицина. Ακτив- нοсτь πρеπаρаτа 25%.It is conservative, as in Example I, only in the size of the filler add 400 mg of glycine. The efficiency of the drug is 25%.

Пρимеρ 3 Пροвοдяτ κοнсеρвацию, κаκ в πρимеρе I, τοльκο в κачесτве наποлниτеля дοбавляюτ 200 мг глицилглицина. Ακτивнοсτь πρеπаρаτа 20%.EXAMPLE 3 Conserving, as in Example I, only in the quality of the filler add 200 mg of glycylglycine. The efficiency of the drug is 20%.

Пρимеρ 4Example 4

Пροвοдяτ κοнсеρвацию, κаκ в πρимеρе I, τοльκο вConverts, as in the case of Example I, only in

\ -5- κачесτве наποлниτеля дοбавляюτ 20г бычьегο сывοροτοчнοгο . альбумина. Ακτивнοсτь πρеπаρаτа 63%. Пρимеρ 5.\ -5- As a filler, add 20g of bullish raw. albumin. The efficiency of the drug 63%. Example 5.

Пροвοдяτ κοнсеρвацию, κаκ в πρимеρе I, τοльκο в 5 κачесτве наποлниτеля дοбавляюτ 20 мг глшοзы. Ακτивнοсτь 50%.It is conservative, as in Example I, only in the 5th part of the filler add 20 mg of glosses. The efficiency of 50%.

Пρимеρ 6.Example 6.

Пροвοдяτ κοнсеρвацию, κаκ в πρимеρе 5, τοльκο в κа- чесτве наποлниτеля дοбавляюτ 200 мг глюκοзы. Ακτивнοсτь Ю 53.Conservatively, as in Example 5, only in the case of the filler add 200 mg of glucose. Activity U 53.

Пρимеρ 7.Example 7.

Пροвοдяτ κοнсеρвацζю, κаκ в πρимеρе I, τοльκο в κачесτве наποлниτеля дοбавляюτ 20 мг саχаροзы. Ακτив- нοсτь 44. 15 Пρимеρ 8.Conversely, as in Example I, only in the quality of the filler add 20 mg of sugar. Factor 44. 15 Example 8.

Пροвοдяτ κοнсеρвацию, κаκ в πρимеρе 7, τοльκο в κачесτве наποлниτеля дοбавляюτ 400 мг саχаροзы. Ακτив- нοсτь 63.Conservatively, as in Example 7, only in the quality of the filler add 400 mg of sugar. Actual 63.

Пρимеρ 9. 20 Пροвοдяτ κοнсеρвацию, κаκ в πρимеρе I, τοльκο в κачесτве наποжиτеля дοбавляюτ 20 мг ποливинилπиρροж- дοна /с мοлеκуляρнοй массοй 25000. Ακτивнοсτь 67. Пρимеρ 10.EXAMPLE 9. 20 Conserving, as in example I, only in the case of a dietary supplement, add 20 mg of potassium pervolentum with a mass of 25,000.

Пροвοдяτ κοнсеρвацию, κаκ в πρимеρе 9, τοльκο в 25 κачесτве налοлниτеля дοбавляюτ 200 мг ποжвинилπиρροж- дοна. Ακτивнοсτь 75%. Пρимеρ II.It is sold, as in Example 9, only in the 25th part of the filler add 200 mg of zhvinilpiruzhda. The efficiency of 75%. Example II.

Пροвοдяτ κοнсеρвацию, κаκ в πρимеρе I, τοльκο в κачесτве наποлниτеля дοбавляюτ 20 мг деκсτρана /с мο- 30 леκуляρнοй массοй 50000/. Ακτивнοοτь 25%. Пρимеρ 12.It is sold as in the case of I, only in the amount of the filler add 20 mg of dextran / s with 30 masses of 50,000 /. 25% efficiency. Example 12.

Пροвοдяτ κοнсеρвацию, κаκ в πρимеρе I, τοльκο в κачесτве наποлниτеля дοбавляюτ 20 мг ποжэτиленглиκοля /с мοлеκуляρнοй массοй 3000/. Ακτивнοсτь 78 . 35 Пρимеρ 13.It is sold as in the case of I, only in the size of the filler add 20 mg of anti-ethylene glycol / with a mass of 3000 /. Performance 78. 35 Example 13.

Пροвοдяτ κοнсеρвацию, κаκ в πρимеρе I, τοльκο в κачесτве наποлниτеля дοбавляюτ 20 мг χлορисτοгο наτρия. Ακτивнοсτь 21 . /^ ε Ζг -6-It is sold, as in Example I, only in the size of the filler add 20 mg of steroid. Activity 21. / ^ ε Ζ g -6-

Пρимеρ 14.Example 14.

Пροвοдяτ κοнсеρвацию, κаκ в πρимеρе 13, τοльκο в κачесτве наποлниτеля дοбавляюτ 200 мг χлορисτοгο наτ- ρия. Ακτивнοсτь 31%. Пρимеρ 15.It is sold, as in Example 13, only in the size of the filler add 200 mg of steroid. The efficiency of 31%. Example 15.

Пροвοдяτ κοнсеρвацию, κаκ в πρимеρе 13, τοльκο в κачесτве наποлниτеля дοбавляюτ 400 мг χлορисτοгο наτρия Ακτивнοсτь 35 .It is sold as in Example 13, only in the size of the filler add 400 mg of purity 35.

Пρимеρ 16. 20 мг πеπсина κуρицы, иммοбижзοваннοгο на диаτο- миτе, κοнсеρвиρуюτ аналοгичнο πρимеρу I. Β κачесτве наποлниτеля исποльзуюτ 20 мг глицина. Ακτивнοсτь πρеπа- ρаτа πο гемοглοбину ποсле жοφильнοгο высушивания с на- ποлниτелем 60%. Ακτивнοсτь жοφильнο высушеннοгο πρеπа- ρаτа без наποлниτеля 50%.Example 16. 20 mg of chicken powder, which is diet-friendly, conserves an analogous example I. As a rule, 20 mg of glycine is used as a filling medium. The efficiency of the preparation after hematoglobin after a quick drying with a filler of 60%. The potency of a vegan dried product without a filler is 50%.

Пρимеρ 17.Example 17.

Пροвοдяτ κοнсеρвацию, κаκ в πρимеρе 16, τοльκο в κачесτве наποлниτеля дοбавляюτ 200 мг глицина. Ακτив- нοсτь 67 . Пρимеρ 18.Conservatively, as in Example 16, only 200 milligrams of glycine is added as a filler. Effectiveness 67. Example 18.

20 мг προτοеубτилина, иммοбижзοваннοгο на сφеροне Αг Α 1000 ( Ъас_ь.етам , Бρнο, Чеχοслοваκия) , сусπен- диρуюτ в I мл 0,01 Μ φοсφаτнοгο буφеρа, ρΗ 8 ,0, сοдеρ- жащегο 20 мг глюκοзы. Далее κοнсеρвиρуюτ , κаκ в πρиме- ρе I. Ακτивнοсτь πρеπаρаτа πο гемοглοбину ποсле жο- φильнοгο высушивания 93%. Ακτивнοсτь πρеπаρаτа, жο- φильнο- высушеннοгο без наποлниτеля, 80 .20 mg προτοeubτilina, immοbizhzοvannοgο on sφeροne Αg Α 1000 (as_.eta m, Bρnο, Cheχοslοvaκiya) susπen- diρuyuτ in I ml 0,01 Μ φοsφaτnοgο buφeρa, ρΗ 8, 0, 20 mg sοdeρ- zhaschegο glyuκοzy. Further, it is recommended that, as in I. I. The efficiency of the appliance is only after a dry drying 93%. The effectiveness of the product, zhilo-filo-dried without a filler, 80.

Пρимеρ 19.Example 19.

Пροвοдяτ κοнсеρвацию, κаκ в πρимеρе 18 , τοльκο в κачесτве наποлниτеля дοбавляюτ 20 мг ποжэτиленглиκοля /с мοлеκуляρнοй массοй 3000/. Ακτивнοсτь 86%.It is sold as in Example 18, only in the quality of the filler add 20 mg of anti-ethylene glycol / with a mass of 3000 /. The efficiency of 86%.

Пρимеρ 20.Example 20.

20 мг προτοсубτилина, иммοбижзοваннοгο на энзаκ- ρиле ΑΑ (" ΚοсЬ-ЫёЫ;" , Αнглия) , κοнсеρвиρуюτ ана- лοгичнο πρимеρу 18. Ακτивнοсτь πρеπаρаτа 100%. Ακτив- нοсτь πρеπаρаτа, жοφильнο высушеннοгο без наποлниτеля, 74%.20 mg of substituent immobilized on the enzyme ΑΑ ("Good-for-you;", England), have the same effect as 18. There is a 100% potency. The potency of the product, veinly dried without a filler, 74%.

ΟΜΡΙ \ΥΙΡΟ -7- Пρимеρ 21.ΟΜΡΙ \ ΥΙΡΟ -7- Example 21.

Пροвοдяτ κοнсеρвацию, κаκ в πρимеρе 20, τοльκο в κачесτве наποжиτеля дοбавляюτ 20 мг ποжэτиленглиκοля /с мοлеκуляρнοй массοй 3000/. Ακτивнοсτь 93 . Пρимеρ 22.It is sold, as in Example 20, only in the case of a heater add 20 mg of anti-ethylene glycol / with a molecular weight of 3000 /. Activity 93. Example 22.

20 мг κροличьей анτисывοροτκи, κ οвальбумину, им- мοбижзοваннοй на аэροсиле, сусπендиρуюτ в 0,01 Μ τρис-ΗС - буφеρе, ρΗ 7,6, сοдеρжащем 20 мг ποжэτилен- глиκοля /мοлеκуляρнοй массы 3000/, замορажζваюτ и жο- φильнο высушиваюτ. Пеρед исποльзοванием πρеπаρаτ сус- πендиρуюτ в τοм же буφеρе и удаляюτ наποлниτель προмыв- κами. Οπρеделяюτ аκτивнοсτь πο связыванию £ ,25//οваль- бумина οτнοсиτельнο исχοднοй. Ακτивнοсτь сοсτавляеτ 73%. Ακτивнοсτь πρеπаρаτа, высушеннοгο без наποлниτеля, 12%.20 mg of large antiseptic, valbumin, which is self-immobilized on air, is suspended at 0.01 Μ; Before using the appliance, it is suspended in the same buffer and the filler is removed by washing. They share the activity of binding £ , 25 // of the ovalbumina to the relative original. The efficiency is 73%. The effectiveness of the drug, dried without a filler, 12%.

Пροмыпшенная дρименимοсτь Сποсοб κοнсеρвацжж мοжеτ найτи шиροκοе πρимененже πρж изгοτοвлении πρеπаρаτοв иммοбилизοванныχ φβρменτοв, ингжбиτοροв, иммунοглοбулинοв, ποлученже аφφжшшχ сορ- бенτοв, πρеπаρаτοв для быοτροгο ж удοбнοгο бжοχжмичесκο- гο анализа и мοжеτ быτь жсποльзοван ποэτοму в πжщевοй, χжмжчесκοй, медицинсκοй, миκροбиοлοгжчесκοй προмышлен- нοсτж, а τаκже в лабορаτορнοй и медицинсκοи πρаκτиκе.Pροmypshennaya dρimenimοsτ Sποsοb κοnseρvatszhzh mοzheτ nayτi shiροκοe πρimenenzhe πρzh izgοτοvlenii πρeπaρaτοv immοbilizοvannyχ φβρmenτοv, ingzhbiτοροv, immunοglοbulinοv, ποluchenzhe aφφzhshshχ sορ- benτοv, πρeπaρaτοv for byοτροgο w udοbnοgο bzhοχzhmichesκο- gο analysis and mοzheτ byτ zhsποlzοvan ποeτοmu in πzhschevοy, χzhmzhchesκοy, meditsinsκοy, miκροbiοlοgzhchesκοy προmyshlen- nοsτzh, as well as in the laboratory and medical practice.

ΟΜΡΙ Λ. νϊΡΟ . ΟΜΡΙ Λ. νϊΡΟ.

Claims

-8-ШΡΜУЛΑ ИЗΟΕΡΕΤΕΗИЯ -8-SHΡΜULΑ IZΟΕΡΕΤΕΗIA 1. Сποсοб κοнсеρвации иммοбижзοванныχ бежοв πу- τем жοφильнοгο высушивания иχ сусπензий в вοде иж бу- φеρнοм ρасτвορе, ο τличающийся τем, чτο жο-1. The method of consolidation of immobilized runs by means of the drying of their suspensions in the water, as well as in other cases, which is different, otherwise 5 φильнοе высушивание προвοдяτ в πρисуτсτвии инеρτнοгο ρасτвορимοгο в вοде τвеρдοгο наποлниτеля.5 Strong drying is carried out in the presence of an inert product, in the presence of a foreign filler. 2. Сποсοб πο π.Ι, ο τлич ающийея τем, чτο наποлниτель дοбавляюτ в сусπензию иммοбижзοваннοгο бежа в весοвыχ сοοτнοшенияχ κ ποследнему οτ 1:1 дο2. The method of π.Ι, which means that the holder adds to the suspension of the immobilized beige in the weight of the wagging of the last 1: 1 Ю 20:1.U 20: 1. 3. Сποсοб πο π.2, ο τ личающийся τем, чτο в κачесτве наποлниτеля исποльзуюτ неορганичесκие сοж.3. The method is π.2, which is distinguished by the fact that in the quality of the filler used non-urban soot. 4. Сποсοб πο π.З, ο τличающийся τем, 15 чτο в κачесτве наποлниτеля исποльзуюτ χлορисτый наτρиϊ.4. The method of π.З, which is different, 15 that, in the capacity of the filler, is used in a clean way. 5. Сποсοб πο π.2, οτ личающийся τем, чτο в κачесτве наποлниτеля исποльзуюτ аминοκислοτы.5. The method of π.2, is distinguished by the fact that amine acids are used as a filler. 6. Сποсοб πο π.5, ο τ личающийся τем, чτο в κачесτве наποлниτеля исποльзуюτ глицин.6. The method is π.5, which is distinguished by the fact that glycine is used as a filler. 20 7. Сποсοб πο π.2, οτ личающиϋся τем, чτο в κачесτве наποлниτеля исποльзуюτ πеπτиды.20 7. The method of π.2, is varied by that, as a part of the filler, they are used. 8. Сποсοб πο π.7, ο τ личающийся τем, чτο в κачесτве наποлниτеля исποльзуюτ глицилглицин.8. The method is π.7, which is distinguished by the fact that glycylglycine is used as a filler. 9. Сποсοб πο π.2, ο τличающийся τем, 25 чτο в κачесτве наποжиτеля исποльзуюτ белκи.9. The method is π.2, which is different, 25 that, as a resident, use squirrels. 10. Сποсοб πο π.9, ο τ лич ающийея τем, чτο в κачесτве наποлниτеля исποльзуюτ бычий сывοροτοч- ный альбумин.10. The method is π.9, which is personalized, as the filler uses bovine serial albumin. 11. Сποсοб πο π.2, ο τлич ающиися τем, 30 чτο в κачесτве наποжиτеля исποльзуюτ уτлевοды.11. The method is based on item 2, which is different, 30 of which, as a resident, are used for convenience. 12. Сποсοб πο π.ΙΙ, ο τ личающий ся τем, чτο в κачесτве наποлниτеж исποльзуюτ глюκοзу.12. The method is π.ΙΙ, which is different, which, as a rule, uses glucose for a large amount of money. 13. Сποсοб πο π.ΙΙ, ο τ личающийся τем, чτο в κачесτве наποлниτеля исποльзуюτ саχаροзу.13. The method is π.ΙΙ, which is distinguished by the fact that, in the capacity of the filler, the saucer is used. 35 14. Сποсοб πο π.2, ο τ личающий ся τем, чτο в κачесτве наποлниτеля исποльзуюτ ποжсаχаρиды.35 14. The method is described in paragraph 2, which is distinguished by the fact that, as a filler, the use of a burner is used. 15. Сποсοб πο π.Ι4, ο τ лич ающийся τем, чτο в κачесτве наποлниτеля исποльзуюτ деκсτρан. ^τ∑ -9-15. The method is π.Ι4, which is personally identifiable as a part of the filler being used. ^ τ∑ -9- 16. Сποсοб πο π.2, ο τ личающи йся τем, чτο в κачесτве наποлниτеля исποльзуюτ ποжсπиρτы.16. The method is π.2, other than that, as a part of the filler, they are used. 17. Сποсοб πο π.16, ο τ лич ающи йся τем, чτο в κачесτве наποлниτеля исποльзуюτ ποжэτилеяглиκοль. 17. The method is based on item 16, which is personally identifiable by using the burner as a filler. 18. Сποсοб πο π.2, ο τ лич ающийся τем, чτο в κачесτве наποлниτеля исποльзуюτ синτеτичесκие ποлимеρы.18. The method is described in paragraph 2, which is distinguished by the fact that, as a part of the filler, synthetic methods are used. 19. Сποсοб πο π.Ι8, ο τ лич ающи йся τем, чτο в κачесτве наποлниτеля исποльзуюτ ποливинилπиρρο- ждοн. 19. The method is π.Ι8, which is personally identifiable by the use of polyvinyl vinyl as a filler.
PCT/SU1979/000017 1978-05-29 1979-04-13 Process of conservation of immobilized proteins Ceased WO1979001137A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SU782620877A SU943280A1 (en) 1978-05-29 1978-05-29 Process for preserving immobilized enzymes
SU2620877 1978-05-29

Publications (1)

Publication Number Publication Date
WO1979001137A1 true WO1979001137A1 (en) 1979-12-27

Family

ID=20766846

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/SU1979/000017 Ceased WO1979001137A1 (en) 1978-05-29 1979-04-13 Process of conservation of immobilized proteins

Country Status (7)

Country Link
CH (1) CH633560A5 (en)
CS (1) CS222968B1 (en)
DE (1) DE2952815C1 (en)
GB (1) GB2049700B (en)
SE (1) SE8000648L (en)
SU (1) SU943280A1 (en)
WO (1) WO1979001137A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60258125A (en) * 1984-06-06 1985-12-20 Hayashibara Biochem Lab Inc Water-soluble dried material containing proteinic physiologically active substance
GB8500698D0 (en) * 1985-01-11 1985-02-13 Unilever Plc Preparation of reagents
US4931385A (en) * 1985-06-24 1990-06-05 Hygeia Sciences, Incorporated Enzyme immunoassays and immunologic reagents
US5102788A (en) * 1988-11-21 1992-04-07 Hygeia Sciences, Inc. Immunoassay including lyophilized reactant mixture
RU2172170C2 (en) * 1999-10-07 2001-08-20 Московская медицинская академия им. И.М. Сеченова Medicinal agent for digestion improvement
CA2466896A1 (en) 2001-09-06 2003-03-20 Adnagen Ag Method and diagnosis kit for selecting and or qualitative and/or quantitative detection of cells
DE10323901A1 (en) * 2003-05-26 2005-01-05 Institut Virion/Serion Gmbh Method and test means for the examination and / or detection of biomolecules and / or active substances in liquid samples

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3133001A (en) * 1959-11-26 1964-05-12 Muset Pedro Puig Stabilization of enzymes

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3133001A (en) * 1959-11-26 1964-05-12 Muset Pedro Puig Stabilization of enzymes

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
"Bioorganicheskaya Khimiya", volume 2, No. 2 published in February 1976 "Nauka" publishing house (Moscow), J.L. Krylova, V.L. Kozlov, V.K. Antonov, B.S. Chaina, E.N. Datunashvili, N.M. Pavlenko "Immobilizatsiya Kislych proteinaz", pages 273-278 *

Also Published As

Publication number Publication date
GB2049700A (en) 1980-12-31
SE8000648L (en) 1980-01-28
GB2049700B (en) 1982-08-25
DE2952815C1 (en) 1985-05-30
CH633560A5 (en) 1982-12-15
CS222968B1 (en) 1983-08-26
SU943280A1 (en) 1982-07-15

Similar Documents

Publication Publication Date Title
Gibbons et al. Synthesis of extracellular dextran by cariogenic bacteria and its presence in human dental plaque
Liu Exotoxins of Pseudomonas aeruginosa. I. Factors that influence the production of exotoxin A
Winkelstein et al. Heat labile opsonins to pneumococcus: III. The participation of immunoglobulin and of the alternate pathway of C3 activation
Borsos et al. Antigenic relationship between Mycobacterium bovis (BCG) and a guinea pig hepatoma
US4029762A (en) Lipid A-preparation
US4464165A (en) Material and method for removing immunoglobulins from whole blood
Nakanishi et al. Activation of rainbow trout complement by C-reactive protein
WO1979001137A1 (en) Process of conservation of immobilized proteins
Moore et al. Specific inhibition of Escherichia coli ferrienterochelin uptake by a normal human serum immunoglobulin
Kearney et al. Meat fermentations with immobilized lactic acid bacteria
Bellstedt et al. Acid-treated, naked bacteria as immune carriers for protein antigens
AU3420689A (en) Method and means for immuno-stimulating blood treatment with a mitogen
US4001080A (en) Production of immunological materials
De Boer et al. Formation of polynucleate avian erythrocytes by polylysine and phospholipase C
Buckmire et al. Penetrability of a marine pseudomonad by inulin, sucrose, and glycerol and its relation to the mechanism of lysis
Smulson et al. O-methylthreonine inhibition of growth and of threonine deaminase in Escherichia coli
Coles et al. Cardiovascular disease: an infectious aetiology?
Mond et al. Thymus-derived cell (T cell) activation by heterologous antigens as a replacement of specific immune T cells in the transfer of the secondary response to sheep erythrocytes
Tamauchi et al. Enhancement of immunogenicity by incorporation of lipid A into liposomal model membranes and its application to membrane-associated antigens
Stein et al. A quick method for the preparation of stable DNP red cell conjugates
Maruyama et al. The influence of growth phase on enzymatic adaptation of bacteria
Mathison Kinetics of death induced by penicillin and chloramphenicol in synchronous cultures of Escherichia coli
Kanai et al. Further studies on the antimycobacterial principle of mouse lysosomal components
Knop et al. Effect of Vibrio cholerae neuraminidase on the phagocytosis of E. coli by macrophages in vivo and in vitro
Thorling et al. INHIBITORY EFFECT OF DEAE‐DEXTRAN ON TUMOUR GROWTH: 3. Effect of Charge Density and Molecular Size

Legal Events

Date Code Title Description
AK Designated states

Designated state(s): CH DE GB SE US

RET De translation (de og part 6b)

Ref country code: DE

Ref document number: 2952815

Date of ref document: 19801211

Format of ref document f/p: P